Alpha 2.0
Login Register
» Articles » PMID: 17715371

Human Immunodeficiency Virus Type 1 (HIV-1) Plasma Load Discrepancies Between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Assays

Overview
Journal J Clin Microbiol
Specialty Microbiology
Date 2007 Aug 24
PMID 17715371
Citations 32
Authors
F Damond
B Roquebert
A Benard
G Collin
M Miceli
P Yeni
F Brun-Vezinet
D Descamps
Affiliations
Soon will be listed here.
Abstract

We compared plasma viral load values obtained with COBAS AMPLICOR human immunodeficiency virus type 1 (HIV-1) MONITOR version 1.5 and with COBAS TaqMan HIV-1 assays. Mean values were 4.2 and 2.9 log(10) copies/ml, respectively, showing the lack of agreement between the two assays.

Citing Articles

Cognitive Performance, as well as Depression, Alcohol Use, and Gender, predict Anti-Retroviral Therapy Adherence in a South African Cohort of People with HIV and Comorbid Major Depressive Disorder.

Dreyer A, Nightingale S, Andersen L, Lee J, Gouse H, Safren S AIDS Behav. 2023; 27(8):2681-2694.

PMID: 36708417 PMC: 10338393. DOI: 10.1007/s10461-023-03992-7.

Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test.

Manohar C, Sun J, Schlag P, Santini C, Fontecha M, Lotscher P Heliyon. 2022; 8(9):e10591.

PMID: 36120497 PMC: 9464314. DOI: 10.1016/j.heliyon.2022.e10591.

Studying patterns and predictors of HIV viral suppression using A Big Data approach: a research protocol.

Zhang J, Olatosi B, Yang X, Weissman S, Li Z, Hu J BMC Infect Dis. 2022; 22(1):122.

PMID: 35120435 PMC: 8817473. DOI: 10.1186/s12879-022-07047-5.

Tobacco Use and Health-Related Quality of Life Among Individuals with Depression Who Are Receiving Treatment for HIV in Cape Town, South Africa.

Stanton A, Lee J, Wirtz M, Andersen L, Joska J, Safren S Int J Behav Med. 2021; 28(4):417-430.

PMID: 33511574 PMC: 8266737. DOI: 10.1007/s12529-020-09951-z.

Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial.

Joska J, Andersen L, Smith-Alvarez R, Magidson J, Lee J, OCleirigh C JMIR Res Protoc. 2020; 9(2):e14200.

PMID: 32012114 PMC: 7055790. DOI: 10.2196/14200.

References
1.
Mellors J, Munoz A, Giorgi J, Margolick J, Tassoni C, Gupta P . Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997; 126(12):946-54. DOI: 10.7326/0003-4819-126-12-199706150-00003. View
2.
Berger A, Scherzed L, Sturmer M, Preiser W, Doerr H, Rabenau H . Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation). J Clin Virol. 2002; 25 Suppl 3:S103-7. DOI: 10.1016/s1386-6532(02)00185-3. View
3.
Sninsky J, Kwok S . The application of quantitative polymerase chain reaction to therapeutic monitoring. AIDS. 1993; 7 Suppl 2:S29-34. DOI: 10.1097/00002030-199311002-00007. View
4.
Gueudin M, Plantier J, Lemee V, Schmitt M, Chartier L, Bourlet T . Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007; 44(5):500-5. DOI: 10.1097/QAI.0b013e31803260df. View
5.
Alaeus A, Lidman K, Sonnerborg A, Albert J . Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 1997; 11(7):859-65. DOI: 10.1097/00002030-199707000-00004. View